secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2025-03-07T23:59:59+00:00
Accession:  0001493152-25-009571
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 5.07, 8.01, 5.08, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa raises ~$2M in private placement; special meeting adjourned without quorum
--------------------------------------------------------------------------------

- Gross proceeds of $2M from private placement of pre-funded and common warrants; pre-funded warrants priced at $0.9499.
- Common warrants exercisable at $1.00/share, expire 5 years after stockholder approval.
- Existing warrants from Nov 2024 amended to reduce exercise price to $1.00 per share.
- Special meeting on Mar 4 lacked quorum; proposals move to 2025 annual meeting set for June 11, 2025.
- Record date for 2025 annual meeting is April 15, 2025; stockholder proposals due by March 17, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315225009571/0001493152-25-009571-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315225009571/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-009571

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer